Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com Prev Post Multiple New Multi-Commodity Targets May 12, 2025 Next Post Excellent Gold Intersections Verified at Kiimala Project May 12, 2025 Related Posts NioCorp Acquires FEA Materials to Build US Scandium Supply Chain December 6, 2025 Copper Quest Closes $1,927,000 Private Placement December 6, 2025 Editor’s Picks: Silver Price Smashes All-time High, Nearly Hits US$60 December 6, 2025